Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

During the Trading Day
331.15 +2.28 / +0.69%
As of 4:05pm ET
Day’s Change
During After-Hours   Switch to standard view »
331.15 +0.003 / +0.00%
 
Volume: 109.2K

Today’s Trading

Previous close328.87
Today’s open328.50
Day’s range326.29 - 332.48
Volume2,903,906
Average volume (3 months)2,152,244
Market cap$129.1B
Dividend yield--
Data as of 4:05pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.59%
Earnings growth (next 5 years)+15.30%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.42+0.78%
NVONovo Nordisk+0.68+1.17%
ABBVAbbVie-0.15-0.21%
BMYBristol-Myers Squibb+1.18+1.83%
Data as of 4:04pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$4.38
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts